Coverage with Evidence Development; Economics; Evidence based healthcare; Insurance coverage
Indexed keywords
CRITICAL CHALLENGES;
DATA COLLECTION;
DEGREE OF UNCERTAINTY;
HEALTH TECHNOLOGY ASSESSMENTS;
HEALTH-CARE INSURANCE;
MEDICAL LITERATURES;
NEW TECHNOLOGIES;
REAL-WORLD;
INNOVATION;
INSURANCE;
TECHNOLOGICAL FORECASTING;
TECHNOLOGY TRANSFER;
BIOMEDICAL TECHNOLOGY ASSESSMENT;
CONSENSUS;
COST EFFECTIVENESS ANALYSIS;
DRUG INDUSTRY;
EVIDENCE BASED PRACTICE;
HUMAN;
REVIEW;
APPARATUS, EQUIPMENT AND SUPPLIES;
ARTICLE;
COST BENEFIT ANALYSIS;
ECONOMICS;
EVIDENCE BASED MEDICINE;
HEALTH INSURANCE;
INSURANCE;
ORGANIZATION AND MANAGEMENT;
RISK MANAGEMENT;
SURGERY;
TREATMENT OUTCOME;
Centers for Medicare and Medicaid Services. National coverage determinations with data collection as a condition of coverage: Coverage with evidence development. 2006. http://www. cms.hhs.gov/mcd/ncpc-view-document.asp? id = 8 (accessed February 10, 2009).
Outcomes guarantee for lipid-lowering drugs: Results from a novel approach to risk sharing in primary care
Chapman S, Reeve E, Price D, Rajaratnam G, Neary R. Outcomes guarantee for lipid-lowering drugs: results from a novel approach to risk sharing in primary care. Br J Cardiol. 2004;11:205-210.
Claxton K. Pricing, innovation and NICE in the UK. Presented at the Second Biennial Conference of the American Society of Health Economists. Equity and efficiency in health and healthcare. 2008, June 22-25. Duke University.
Using value of information analysis to prioritise health research: Some lessons from recent UK experience (Conference Paper)
Claxton K, SculpherMJ. Using value of information analysis to prioritise health research: Some lessons from recent UK experience (Conference Paper). Pharmacoeconomics. 2006;24:1055-1068.
Building bridges between academic research and policy formulation: The PRUFE Framework-an Integral Part of Ontario's Evidence-Based HTPA Process
Goeree R, Levin L. Building bridges between academic research and policy formulation: The PRUFE Framework-an Integral Part of Ontario's Evidence-Based HTPA Process. Pharmacoeconomics. 2006;24:1143-1156.
Coverage with evidence development: An examination of conceptual and policy issues
Hutton J, Trueman P, Henshall C. Coverage with evidence development: An examination of conceptual and policy issues. Int J Technol Assess Health Care. 2007;23:425-435.
Medicare Australia. Physician's guide. A guide to prescribing treatment for primary pulmonary hypertension and pulmonary arterial hypertension within the Pharmaceutical Benefits Scheme Selection 100 restriction criteria. Sydney: Australian Government; 2008.
Dealing with uncertainty in Medicare coverage decisions
Presented at Montreal, Canada
Tunis S. Dealing with uncertainty in Medicare coverage decisions. Presented at the Health Technology Assessment International Annual Meeting. 2008. Montreal, Canada.
Public funding of bosentan for the treatment of pulmonary artery hypertension in Australia
Wlodarczyk JH, Cleland LG, Keogh AM, et al. Public funding of bosentan for the treatment of pulmonary artery hypertension in Australia. Pharmacoeconomics. 2006;24:903-915.